Pharma 2023 (Reuters Events)
Pioneering the field of precision medicine, NeuroKaire (formerly Genetika+) employs state-of-the-art technology to transform extensive datasets into actionable insights.
Our Director of Business Development, David Pattison, represented NeuroKaire (formerly Genetika+) at the Health Start-up Challenge during Reuters Events: Pharma 2023 in Barcelona from 18-20 April.
David joined forces with other pharma leaders to discuss and explore new ideas that will revolutionize the industry and reinvent healthcare.
As a result, NeuroKaire (formerly Genetika+) won the Health Start-up Challenge and was subsequently featured in an exclusive interview with Reuters Events. Read more here: https://www.reutersevents.com/pharma/commercial/genetika-transforming-digital-health-precision-medicine-innovations. We are excited to be acknowledged for making a positive impact in the pharma industry.
Schedule a Meet & Greet
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel